CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 85 enrolled
Drug / intervention
Australian Spasticity Assessment Scaleother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04613661
NCT04613661N/ACompleted
CompareCT.gov

Inter-rater Reliability of the Australian Spasticity Assessment Scale (ASAS) in Post-stroke Spasticity

Izmir Katip Celebi University·observational·Posted Nov 3, 2020·Updated Feb 15, 2022

In Brief

An observational study evaluating Australian Spasticity Assessment Scale for Hemiplegia, Spastic. Completed, enrolled 85 participants across 1 site.

Detailed Summary

The reliability of the Australian Spasticity Assessment Scale (ASAS) has been reported to be not high enough in adult patients with acquired brain damage. The low number of patients and the heterogeneous study population have been reported as important limitations in the reliability study of this measure. Therefore, the reliability of the ASAS needs to be confirmed in stroke patients with spasticity. This study aims to investigate the inter-rater reliability of the ASAS in a study population consisting of a larger and more homogeneous patient population (those with post-stroke spasticity).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemiplegia, Spastic
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 3, 2020
Enrollment StartOct 20, 2020
Primary CompletionDec 17, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.7 years ago

Interventions

Australian Spasticity Assessment Scaleother

Australian Spasticity Assessment Scale is a clinical measure to assess the severity of spasticity